Skip to content

AQSE company news


Back to news

Aquis Stock Exchange Weekly Highlights 29/04/24



April 29, 2024

Most recent

SulNOx Group PLC provided a Q4 (January-March) and full year trading update for the year ending 31 March 2024.
Financial Highlights
  • Unaudited Q4 revenues amounted to £314,995, marking a 201% increase from Q3 (£104,572) and a significant 282% rise compared to Q4 2023 (£82,546), which the Company states was a record trading quarter, driven by expanding marine sales and associated third party emission monitoring equipment (£85,934), as well as new and repeat sales in Asia.
  • Unaudited full year revenues for the period ending 31 March 2024 amounted to £555,290, almost triple the previous year (£203,061).
  • SulNOx says Q1 has also started positively, with committed sales of c. £105,000 and a strong revenue pipeline as repeat orders are placed for Ghana and marine evaluations continue to grow in both number and wider usage across fleets.
  • Unaudited year end cash balance of £2.15 million.
    Read more…
Marula Mining PLC announced that, further to the announcement in March 2024, the eight new Mining License Applications made by NyoriGreen Mining Limited have been granted. The granting of the Prospecting License that was also applied for, remains outstanding and is still expected to be issued in Q2 2024. These New Licenses are valid for a period of seven years, effective from 19 April 2024 and are being incorporated into the now expanded Nyorinyori Graphite Project and the NyoriGreen Graphite Project under the existing commercial and technical services agreements, through which Marula has secured its 75% commercial interest through the funding of exploration, mining and development activities. Read more…
EDX Medical Group plc announced that its ordinary shares are now eligible to commence trading on the Apex segment of the Aquis Stock Exchange with effect from 29 April 2024. The Apex segment is reserved for larger, more established businesses with a proven growth strategy, and which meet high standards of corporate governance. These strict eligibility criteria include having at least 25% of shares in public hands, a minimum of 25 shareholders and a two-year consolidated trading history and compliance with the QCA Code or the UK corporate governance code.
Dr Mike Hudson, CEO, EDX Medical Group plc, said: "We are delighted to become part of the Apex segment on the Aquis Stock Exchange. This move reflects the success of our growth strategy since admission to the market in November 2022 and the evolution of our business. We were particularly pleased with the support from investors during our successful fund raising earlier this year which enables us to accelerate our product development programme. Our move to the Apex segment will provide further visibility for investors, and we welcome the increased emphasis on transparency, liquidity, and corporate governance, which align strongly with our own values." Read more…
Vinanz Limited announced that the first ten S21 Bitmain Antminer 200 Terahash/second miners ordered for their Canadian BlockLABS fleet, as announced on in March, are now fully operational and are all spinning at better than 200 TH/s. Read more…
Back to news


  • About
  • News
  • Investor Relations
  • Contact
  • Careers

© Aquis Exchange 2024. All rights reserved.

Terms & ConditionsPrivacy PolicyModern Slavery & Human Trafficking Policy
System statusnormal